<scp>UHRF1</scp> regulation of the Keap1–Nrf2 pathway in pancreatic cancer contributes to oncogenesis
Wafa AbuAlainin(University of Liverpool), Eithne Costello(University of Liverpool), Christopher E. Goldring(University of Liverpool), Lawrence N. Barrera(University of Liverpool), William Greenhalf(University of Liverpool), Taoufik Nedjadi(National Guard Health Affairs), Brian K. Park(University of Liverpool), John P. Neoptolemos(University of Liverpool), Michael C. Schmid(University of Liverpool), Robert Ferguson(University of Liverpool), Triantafillos Liloglou(University of Liverpool), Joseph R. Slupsky(Cancer Research Center), Fiona Campbell(University of Birmingham), Timothy Andrews(University of Liverpool), Neil R. Kitteringham(University of Liverpool), Thompson Gana(University of Liverpool)
Cited by 58
Related Papers
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k